TABLE 5.
Randomized controlled primary intervention trials for egg allergy.
Study name | Population | Form of egg | Dose | Primary outcome | Main result | Reference |
---|---|---|---|---|---|---|
STAR | 86 infants with moderate‐to‐severe eczema | Pasteurized raw egg powder | 0.9 g of egg protein per day | Egg allergy on oral challenge and positive SPT to egg | A non‐significant reduction of IgE mediated egg allergy in the egg group compared with the control group | 94 |
EAT | 1303 infants from general population | Cooked egg (together with 5 other types of allergens) | 2 g/week | Food allergy following oral food challenge | Intention‐to‐treat analysis: a non‐significant reduction of egg allergy in the early introduction group.Per‐protocol analysis: a Significant reduction of egg allergy in the early introduction group. | 97 |
STEP | 820 infants with hereditary risk | Pasteurized raw whole egg powder | 0.4 g of egg protein per day | Egg allergy on oral challenge and positive SPT to egg | A non‐significant reduction of IgE mediated egg allergy in the egg group compared with the control group | 93 |
BEAT | 319 infants with hereditary risk | Pasteurized raw whole egg powder | 0.35 g of egg protein per day | Sensitization to white egg based on SPT | A reduction in the proportion of infants sensitized to EW in the egg group compared with the control group | 92 |
HEAP | 380 infants from general population | Pasteurized EW powder | 2.5 g per week, 3 times a week (equivalent to 0.83 g of egg protein 3 times a week) | Sensitization to hen's egg, based on increased specific serum IgE levels | A non‐significant augmentation of egg sensitized infants in the egg group | 96 |
PETIT | 147 infants with eczema | Heated egg powder | 50 mg of heated egg powder (equivalent to 25 mg of egg protein and 0.2 g of boiled egg), then 250 mg per day of egg powder | Egg allergy on oral food challenge | A significant reduction of egg allergies in the egg group compared with the control group | 95 |
Abbreviation: EW, egg white.